مرکز تحقیقات رادیولوژی نوین و تهاجمی | کلیدواژه

مرکز تحقیقات رادیولوژی نوین و تهاجمی | کلیدواژه
سایت دانشگاه | 28 آبان 1405
logo

مرکز تحقیقات رادیولوژی نوین و تهاجمی

دانشگاه علوم پزشکی تهران

intra-articular injections of  mesenchymal stromal cells in knee

intra-articular injections of mesenchymal stromal cells in knee

https://adir.tums.ac.ir//article/Three-intra–articular-injections-of-allogeneic-umbilical-cord–derived-mesenchymal-stromal-cells-in-knee-osteoarthritis:-a-phase–I-clinical-trial

Three intra-articular injections of allogeneic umbilical cord-derived mesenchymal stromal cells in knee osteoarthritis a phase-I clinical trial Purpose This phase I clinical trial evaluated the safety and preliminary efficacy of three intra-articular injections of 20 × 106 allogeneic Umbilical Cord-derived Mesenchymal Stromal Cells (UC-MSCs) in patients with Knee Osteoarthritis (OA) at a two-month interval. Methods Six participants aged 40-70 years with Kellgren and Lawrence grade II-III w

menstrual blood stromal cells secretome in COVID-19

menstrual blood stromal cells secretome in COVID-19

https://adir.tums.ac.ir//Research-Article/Safety-and-efficacy-study-of-allogeneic-human-menstrual-blood-stromal-cells-secretome-to-treat-severe-COVID19-patients:-clinical-trial-phase-I-&-II

Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID19 patients clinical trial phase I & II Background Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their capacity to modulate the immune system and suppress cytokine storms caused by SARS-CoV-2. This prospective randomized double-blind placebo-controlled clinical trial aimed to assess the safety and efficacy of secretome derived from allogeneic menstrual blood stromal

متن مورد نظر خود را جستجو کنید
تنظیمات پس زمینه